Author:
Huang Xiao-Jun,Wiernik Peter H,Klein Robert S,Gallagher Robert E
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference22 articles.
1. Chen GQet al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of bcl-2 expression and alteration of PML-RARα/PML protein localization.Blood 1996;88: 1052–1061.
2. Chen GQet al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.Blood 1998;89: 3345–3353.
3. Shen ZXet al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.Blood 1997;89: 3354–3360.
4. Warrell Jr RPet al. Initial western study of arsenic trioxide (AS2O3) in acute promyelocytic leukemia.Proc Am Soc Clin Oncol 1998;17: 6a.
5. Huang XJ, Wiernik PH, Klein RS, Gallagher RE. Potentiation of arsenic trioxide (As2O3) induced apoptosis by retinoic acid (RA) in RA-sensitive (S) and RA-resistant (R) HL-60 myeloid leukemia cells.Blood 1997;90 (Suppl. 1): 329a.
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献